chrX-70146686-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001551.3(IGBP1):āc.536T>Cā(p.Val179Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000407 in 1,204,315 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 24 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Genomes: š 0.000082 ( 0 hom., 4 hem., cov: 21)
Exomes š: 0.000037 ( 0 hom. 20 hem. )
Consequence
IGBP1
NM_001551.3 missense
NM_001551.3 missense
Scores
1
4
12
Clinical Significance
Conservation
PhyloP100: 6.87
Genes affected
IGBP1 (HGNC:5461): (immunoglobulin binding protein 1) The proliferation and differentiation of B cells is dependent upon a B-cell antigen receptor (BCR) complex. Binding of antigens to specific B-cell receptors results in a tyrosine phosphorylation reaction through the BCR complex and leads to multiple signal transduction pathways. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.2177378).
BS2
High Hemizygotes in GnomAd4 at 4 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGBP1 | NM_001551.3 | c.536T>C | p.Val179Ala | missense_variant | 4/7 | ENST00000356413.5 | NP_001542.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGBP1 | ENST00000356413.5 | c.536T>C | p.Val179Ala | missense_variant | 4/7 | 1 | NM_001551.3 | ENSP00000348784.4 | ||
IGBP1 | ENST00000342206.10 | c.536T>C | p.Val179Ala | missense_variant | 3/6 | 1 | ENSP00000363661.5 |
Frequencies
GnomAD3 genomes AF: 0.0000823 AC: 9AN: 109340Hom.: 0 Cov.: 21 AF XY: 0.000126 AC XY: 4AN XY: 31678
GnomAD3 genomes
AF:
AC:
9
AN:
109340
Hom.:
Cov.:
21
AF XY:
AC XY:
4
AN XY:
31678
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000491 AC: 9AN: 183251Hom.: 0 AF XY: 0.0000885 AC XY: 6AN XY: 67779
GnomAD3 exomes
AF:
AC:
9
AN:
183251
Hom.:
AF XY:
AC XY:
6
AN XY:
67779
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000365 AC: 40AN: 1094975Hom.: 0 Cov.: 29 AF XY: 0.0000555 AC XY: 20AN XY: 360457
GnomAD4 exome
AF:
AC:
40
AN:
1094975
Hom.:
Cov.:
29
AF XY:
AC XY:
20
AN XY:
360457
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000823 AC: 9AN: 109340Hom.: 0 Cov.: 21 AF XY: 0.000126 AC XY: 4AN XY: 31678
GnomAD4 genome
AF:
AC:
9
AN:
109340
Hom.:
Cov.:
21
AF XY:
AC XY:
4
AN XY:
31678
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
9
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 18, 2023 | The c.536T>C (p.V179A) alteration is located in exon 4 (coding exon 3) of the IGBP1 gene. This alteration results from a T to C substitution at nucleotide position 536, causing the valine (V) at amino acid position 179 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
IGBP1-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 27, 2022 | The IGBP1 c.536T>C variant is predicted to result in the amino acid substitution p.Val179Ala. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0097% of alleles in individuals of European (Non-Finnish) descent in gnomAD, including seven hemizygous individuals (http://gnomad.broadinstitute.org/variant/X-69366536-T-C). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
.;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;B
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at